Información*
| Nombre | LAURA ELENA DIAZ CUETO |
|---|---|
| Área | MEDICINA Y CIENCIAS DE LA SALUD |
| Campo | INVESTIGACIÓN MÉDICA |
| Disciplina | ONCOLOGÍA, QUIMIOTERAPIA, CIRUGÍA ONCOLOGÍA |
| Especialidad | CANCER |
| CVU | 14781 |
| Institución | |
|---|---|
| Dependencia | OOAD CDMX SUR |
| Entidad | CIUDAD DE MEXICO |
| Nivel | 1 |
| Vigencia | Inicio: 01/01/2023 |
| Fin: 31/12/2027 |
* Información del primer trimestre de 2026.
Fuente: SECIHTI.
Publicaciones ORCID
- 2023
- Ribosomal S6 kinase 4 (RSK4) tumor suppressor gene promoter methylation status in ovarian cancer Molecular Biology Reports
- Ribosomal S6 kinase 4 (RSK4) tumor suppressor gene promoter methylation status in ovarian cancer
- 2021
- Cadmium exposure reduces invasion of the human trophoblast-derived HTR-8/SVneo cells by inhibiting cell adhesion and matrix metalloproteinase-9 secretion Reproductive Toxicology
- 2020
- Progranulin expression induced by follicle-stimulating hormone in ovarian cancer cell lines depends on the histological subtype Medical Oncology
- Inhibition of PI3K/AKT/mTOR and MAPK signaling pathways decreases progranulin expression in ovarian clear cell carcinoma (OCCC) cell line: a potential biomarker for therapy response to signaling pathway inhibitors Medical Oncology
- 2017
- Progranulin and its biological effects in cancer Medical Oncology
